GMJ Medicine
eISSN : 2626-3041
Embase
Biosis Previews
description
Volume 2, Issue 1 (2023)
GMJM 2023, 2(1): 9-13 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2022/06/29 | Accepted: 2023/01/6 | Published: 2023/02/12
Received: 2022/06/29 | Accepted: 2023/01/6 | Published: 2023/02/12
How to cite this article
Noei Alamdary S, Ghasembaglou S. Comparison of Olfactory Quality in Patients with Sinus and Nasal Polyposis Before and After Polypectomy. GMJM 2023; 2 (1) :9-13
URL: http://gmedicine.de/article-2-196-en.html
URL: http://gmedicine.de/article-2-196-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Authors
Sh. Noei Alamdary1, Sh. Ghasembaglou *1
1- Department of Otorhinolaryngology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
Abstract (692 Views)
Aims: Since nasal polyps have a possible role in causing olfactory disorders and olfactory disorders have an effective role in reducing the quality of life, we decided to investigate the role of surgery in the treatment of polyps and then compare the changes in the sense of smell. Therefore, the main purpose of this article is Evaluation of olfactory quality in patients with sinus and nasal polyposis before and after surgery.
Materials & Methods: This descriptive-analytical study was performed with the participation of 72 patients who were candidates for polypectomy surgery during the years 2018-20 in Imam Reza Hospital (Tabriz Medical Sciences) by convenience sampling method. Patients' olfactory status was assessed and compared using Quick olfactory diagnostic test before and after surgery.
Findings: Comparison of the frequency of pre- and postoperative olfactory dysfunction showed that there was a significant difference between the frequency of pre- and postoperative olfactory dysfunction and postoperative olfactory quality showed a significant improvement (p=0.001); Comparison of the frequency of olfactory sense before and after surgery showed that the sense of smell was present in 75% of patients and after surgery in 100% of patients and the observed difference was significant (p=0.004).
Conclusion: There is a significant improvement in the sense of smell of patients undergoing polypectomy.
Materials & Methods: This descriptive-analytical study was performed with the participation of 72 patients who were candidates for polypectomy surgery during the years 2018-20 in Imam Reza Hospital (Tabriz Medical Sciences) by convenience sampling method. Patients' olfactory status was assessed and compared using Quick olfactory diagnostic test before and after surgery.
Findings: Comparison of the frequency of pre- and postoperative olfactory dysfunction showed that there was a significant difference between the frequency of pre- and postoperative olfactory dysfunction and postoperative olfactory quality showed a significant improvement (p=0.001); Comparison of the frequency of olfactory sense before and after surgery showed that the sense of smell was present in 75% of patients and after surgery in 100% of patients and the observed difference was significant (p=0.004).
Conclusion: There is a significant improvement in the sense of smell of patients undergoing polypectomy.
Keywords:
| | Full-Text (HTML) (149 Views)
References
1. Rudmik L, Smith KA, Kilty S. Endoscopic polypectomy in the clinic: a pilot cost-effectiveness analysis. Clin Otolaryngol. 2016;41(2):110-7. [Link] [DOI:10.1111/coa.12473]
2. Velez F, Sacks H, Messina J, Malone D, Smith N, Mahmoud R. cost-effectiveness of eds-flu in sinus surgery candidates who have chronic rhinosinusitis with nasal polyps. Ann Allergy Asthma Immunol. 2018;121(5):S20-1. [Link] [DOI:10.1016/j.anai.2018.09.062]
3. Scangas GA, Lehmann AE, Remenschneider AK, Su BM, Shrime MG, Metson R. The value of frontal sinusotomy for chronic rhinosinusitis with nasal polyps-A cost utility analysis. Laryngoscope. 2018;128(1):43-51. [Link] [DOI:10.1002/lary.26783]
4. Scangas A, Remenschneider AK, Su BM, Shrime MG, Metson R. The impact of asthma on the cost effectiveness of surgery for chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2017;7(11):1035-44. [Link] [DOI:10.1002/alr.22013]
5. Scangas GA, Remenschneider AK, Su BM, Shrime MG, Metson R. Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyposis. Laryngoscope. 2017;127(1):29-37. [Link] [DOI:10.1002/lary.26169]
6. Rudmik L, Soler ZM, Smith TL, Mace JC, Schlosser RJ, DeConde AS. Effect of continued medical therapy on productivity costs for refractory chronic rhinosinusitis. JAMA. 2015;141(11):969-73. [Link] [DOI:10.1001/jamaoto.2015.2321]
7. Chowdhury NI, Mace JC, Smith TL, Rudmik L. What drives productivity loss in chronic rhinosinusitis? A SNOT-22 subdomain analysis. Laryngoscope. 2018:128(1):23-30. [Link] [DOI:10.1002/lary.26723]
8. Velez FF, Sacks HJ, Dennison JC, Smith N, Malone DC, Mahmoud RA. Lifetime work productivity gains among patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with EDS-FLU. J Allergy Clin Immunol. 2019;143:AB281. [Link] [DOI:10.1016/j.jaci.2018.12.858]
9. Velez F, Sacks H, Messina J. Impact of exhalation delivery system with fluticasone on work productivity in the U.S.: results from 2 phase III trials, NAVIGATE 1 and 2. J Manag Care Spec Pharm. 2018;24:S73. [Link]
10. Philpott C, Hopkins C, Erskine S, Kumar N, Robertson A, Farboud A, et al. The burden of revision sinonasal surgery in the uk-data from the chronic rhinosinusitis epidemiology study (CRES): A cross-sectional study. BMJ. 2015;5(4):e006680. [Link] [DOI:10.1136/bmjopen-2014-006680]
11. Stein NR, Jafari A, DeConde AS. Revision rates and time to revision following endoscopic sinus surgery: A large database analysis. Laryngoscope. 2018;128(1):31-6. [Link] [DOI:10.1002/lary.26741]
12. Ference EH, Suh JD, Tan BK, Smith SS. How Often is Sinus Surgery Performed for Chronic Rhinosinusitis with versus without Nasal Polyps?. Am J Rhinol Allergy. 2018;32(1):34-9. [Link] [DOI:10.2500/ajra.2018.32.4495]
13. Mahmoud R, Palmer J, Biletch R. Healthcare for chronic rhinosinusitis (CRS) symptoms -a cross-sectional population-based survey of U.S. adults meeting symptom criteria for CRS. J Allergy Clin Immunol. 2017;139:AB68. [Link] [DOI:10.1016/j.jaci.2016.12.269]
14. Hunter TD, DeConde AS, Manes RP. Disease-related expenditures and revision rates in chronic rhinosinusitis patients after endoscopic sinus surgery. J Med Econ. 2018;21(6):610-5. [Link] [DOI:10.1080/13696998.2018.1452748]
15. Wu XF, Kong WF, Wang WH, Yuan LX, Xu HQ, Qi M, et al. Enhanced recovery after surgery protocols in functional endoscopic sinus surgery for patients with chronic rhinosinusitis with nasal polyps: a randomized clinical trial. Chin. Med. J. 2019;132:253-8. [Link] [DOI:10.1097/CM9.0000000000000060]
16. Bhattacharyya N, Villeneuve S, Joish VN, Amand C, Mannent L, Amin N, et al. Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps. Laryngoscope. 2019;129(9):1969-75. [Link] [DOI:10.1002/lary.27852]
17. McClure NS, Sayah FA, Xie F, Luo N, Johnson JA. Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores. Value Health. 2017;20(4):644-50. [Link] [DOI:10.1016/j.jval.2016.11.015]
18. Chowdhury NI, Mace JC, Bodner TE, Alt JA, Deconde AS, et al. Investigating the minimal clinically important difference for SNOT-22 symptom domains in surgically managed chronic rhinosinusitis. Int Forum Allergy Rhinol. 2017;7(12):1149-55. [Link] [DOI:10.1002/alr.22028]
19. Toma S, Hopkins C. Stratification of SNOT-22 scores into mild, moderate or severe and relationship with other subjective instruments. Rhinology. 2016;54(2):129-33. [Link] [DOI:10.4193/Rhino15.072]
20. Erskine S, Hopkins C, Kumar N, Wilson J, Clark A, Robertson A, et al. A cross sectional analysis of a case-control study about quality of life in CRS in the UK; a comparison between CRS subtypes. Rhinology. 2016;54:311-5. [Link] [DOI:10.4193/Rhino15.361]
21. Cooper T, Greig SR, Zhang H, Seemann R, Wright ED, Vliagoftis H, et al. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study. Auris Nasus Larynx. 2019;46(4):526-32. [Link] [DOI:10.1016/j.anl.2018.12.002]
22. Gray ST, Phillips KM, Hoehle LP, Feng AL, Yamasaki A, Caradonna DS, et al. Utilization patterns of systemic corticosteroid use for chronic rhinosinusitis. Acta Otolaryngol. 2018;138(2):153-8. [Link] [DOI:10.1080/00016489.2017.1380313]
23. Mady LJ, Schwarzbach HL, Boudreau RM, Willson TJ, Lee SE, Moore JA, et al. Air pollutants may be environmental risk factors in chronic rhinosinusitis disease progression. Int Forum Allergy Rhinol. 2018;8(3):377-84. [Link] [DOI:10.1002/alr.22052]
24. Schlosser RJ, Mulligan JK, Hyer JM, Karnezis TT, Gudis DA, Soler ZM. Air pollutants may be environmental risk factors in chronic rhinosinusitis disease progression. JAMA. 2016;142(3):731-7. [Link] [DOI:10.1001/jamaoto.2016.0927]
25. Kohli P, Schlosser RJ, Storck K, Soler ZM. Olfactory cleft computed tomography analysis and olfaction in chronic rhinosinusitis. Am J Rhinol Allergy. 2016;30(6):402-6. [Link] [DOI:10.2500/ajra.2016.30.4365]